Women’s inner-care brand iHEAL is accelerating the expansion of its global footprint by leveraging the robust infrastructure of a listed Japanese company to enter major local offline distribution networks. Beyond simple product exports, it is notable that the company has established a local distribution system capable of activating key drugstore and convenience store channels across Japan, including Don Quijote and Welcia.

BIOLAB, the operating company of the iHEAL brand, announced that it has signed an exclusive supply contract for the Japanese market worth at least KRW 12 billion with its local partner AIDEN LAB JAPAN and the listed Japanese company JELLY BEANS GROUP. Under this three-party agreement, JELLY BEANS GROUP will secure exclusive rights for sales and marketing of the iHEAL brand in Japan.

On the back of this contract, the company plans to significantly raise local brand awareness by expanding consumer contact points through major Japanese distribution networks such as Don Quijote, Welcia, Sugi Pharmacy, and Loft. Building on its performance in the Japanese market, it is also reviewing entry into additional overseas markets, including Southeast Asia.

iHEAL is a brand that has built its presence at home and abroad around its flagship product “iHEAL Venus Probiotics,” which combines lactic acid bacteria derived from the female vagina. In addition to being stocked in more than 700 Olive Young stores in Korea, it has demonstrated differentiated brand competitiveness by winning the Qoo10 Best Award in Japan for two consecutive years.

An iHEAL representative stated, “This contract is the result of the excellent competitiveness of K-feminine care being recognized in the Japanese market,” adding, “Building on this, we will continue our leap forward toward becoming a global women’s health brand.”

Popular News